2.8800.52% ( +0.015 )
Delay Closed: Nov 17, 16:08:15Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: IMMUNEONCO-B(01541) the Revenue is 21.51 M (-10.8%);the EBIT is -81.27 M (+1.95%);the EPS is -0.22 (-7.09%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B10.80%
----
----
EBIT
-0.08B1.95%
----
----
EPS
-0.21987.09%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 26, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
